Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena††Supported in part by Grant No. 24211 from the National Institute of General Medical Science, National Institutes of Health.
- 1 December 1998
- journal article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 87 (12), 1577-1584
- https://doi.org/10.1021/js980171q
Abstract
A precursor-dependent model of indirect pharmacodynamic response which can describe tolerance and rebound was characterized in terms of the effects of changes in the fundamental properties of the drug on its response profiles. The model extends previous models by considering inhibition or stimulation of production of the response variable dependent on the amount of precursor which may accumulate or deplete after administration of some drugs. Standardized pharmacokinetic and pharmacodynamic parameters were used for generating dose, plasma concentration, and response-time profiles using computer simulations. The peak response (Rmax) and the time of its occurrence (TRmax) were dependent on the dose, degree of maximum inhibition (Imax) or stimulation (Smax), and drug concentrations causing 50% inhibition (IC50) or stimulation (SC50). The maximum rebound (RBmax) and the time of its occurrence (TRBmax) after a single bolus dose were also dependent on these factors, but were of lesser magnitude and showed relatively later occurrence. Interestingly, values of area between the baseline and effect curve (ABEC) and area between the baseline and rebound curve (ABRC) were equal for each set of conditions for each model, but the latter is reduced when there is a second pathway for loss of precursor. Tolerance occurs because of diverse mechanisms, and the response patterns demonstrated may be helpful in describing tolerance and rebound phenomena for drugs which affect precursor pools.Keywords
This publication has 12 references indexed in Scilit:
- Transit Compartments versus Gamma Distribution Function To Model Signal Transduction Processes in PharmacodynamicsJournal of Pharmaceutical Sciences, 1998
- Integrated Functions for Four Basic Models of Indirect Pharmacodynamic ResponseJournal of Pharmaceutical Sciences, 1998
- Comparison of four basic models of indirect pharmacodynamic responsesJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Blood Pressure Control—Special Role of the Kidneys and Body FluidsScience, 1991
- Drug- or hormone-induced adaptation: Model of adrenergic hypersensitivityJournal of Pharmacokinetics and Biopharmaceutics, 1989
- Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseasesAmerican Heart Journal, 1988
- Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart FailureNew England Journal of Medicine, 1987
- Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a modelNature, 1985
- Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.JCI Insight, 1980
- A program package for simulation and parameter estimation in pharmacokinetic systemsComputer Programs in Biomedicine, 1979